Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Preferred Stock Liabilities: 2020

Historic Preferred Stock Liabilities for Caribou Biosciences (CRBU) over the last 1 years, with Dec 2020 value amounting to $41.3 million.

  • Caribou Biosciences' Preferred Stock Liabilities was N/A to $41.3 million in Q4 2020 from the same period last year, while for Dec 2020 it was $41.3 million, marking a year-over-year change of. This contributed to the annual value of $41.3 million for FY2020, which is N/A change from last year.
  • According to the latest figures from FY2020, Caribou Biosciences' Preferred Stock Liabilities is $41.3 million.
  • In the past 5 years, Caribou Biosciences' Preferred Stock Liabilities ranged from a high of $41.3 million in FY2020 and a low of $41.3 million during FY2020.
  • In the last 1 years, Caribou Biosciences' Preferred Stock Liabilities had a median value of $41.3 million in 2020 and averaged $41.3 million.